Export 11 results:
Filters: Author is Rabinovici, Gil D [Clear All Filters]
Associations between [F]AV1451 tau PET and CSF measures of tau pathology in a clinical sample.. Neurology. 90(4):e282-e290.
.
2018. CSF neurofilament light chain and phosphorylated tau 181 predict disease progression in PSP.. Neurology. 90(4):e273-e281.
.
2018. Early vs late age at onset frontotemporal dementia and frontotemporal lobar degeneration.. Neurology. 90(12):e1047-e1056.
.
2018. Polygenic hazard score: an enrichment marker for Alzheimer's associated amyloid and tau deposition.. Acta Neuropathol. 135(1):85-93.
.
2018. Prevalence of Mathematical and Visuospatial Learning Disabilities in Patients With Posterior Cortical Atrophy.. JAMA Neurol. 75(6):728-737.
.
2018. Clinicopathological correlations in behavioural variant frontotemporal dementia.. Brain. 140(12):3329-3345.
.
2017. Frontotemporal dementia with the V337M mutation: Tau-PET and pathology correlations.. Neurology. 88(8):758-766.
.
2017. Shared genetic risk between corticobasal degeneration, progressive supranuclear palsy, and frontotemporal dementia.. Acta Neuropathol. 133(5):825-837.
.
2017. Healthy brain connectivity predicts atrophy progression in non-fluent variant of primary progressive aphasia.. Brain. 139(Pt 10):2778-2791.
.
2016. Progression of brain atrophy in PSP and CBS over 6 months and 1 year.. Neurology. 87(19):2016-2025.
.
2016. Timing and significance of pathological features in C9orf72 expansion-associated frontotemporal dementia.. Brain. 139(Pt 12):3202-3216.
.
2016.